Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

CSL to Acquire Novartis' Influenza Vaccine Business

October 27, 2014 8:43 am | News | Comments

CSL Limited today announced that it has agreed to acquire Novartis' global influenza vaccine business for US$275 million. The business will be combined with CSL's subsidiary, bioCSL.            

TOPICS:

Merck's Third Quarter Net Income Falls But Profits Top Analysts' Estimates

October 27, 2014 8:31 am | News | Comments

Merck's third-quarter net income fell mostly because of large costs tied to acquisitions and divestitures. But the company's adjusted earnings topped Wall Street's view, and it narrowed its full-year adjusted earnings forecast on Monday.  

TOPICS:

Zogenix Acquires U.K.-Based Brabant Pharma

October 27, 2014 8:24 am | News | Comments

Zogenix, Inc. today announced that it acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company for $20 million in cash and $15 million in stock plus potential future milestone and royalty payments.      

TOPICS:
Advertisement

Valeant: We'll Bump Allergan Offer to $200 a Share

October 27, 2014 7:33 am | by The Associated Press | News | Comments

Valeant Pharmaceuticals International says it will raise its offer for Botox maker Allergan to $200 or more per share. Valeant made the statement in a letter to Allergan's board released publicly seeking to urge Allergan to talk about an acquisition.

TOPICS:

Drugmakers Bet on Ebola Vaccines, Treatments

October 26, 2014 9:33 am | by Matthew Perrone - Associated Press - Associated Press | News | Comments

Drugmakers are racing to develop vaccines and drugs to address the worst outbreak of Ebola in history. It's unclear who will pay for their products, but companies are betting that governments and aid groups will foot the bill.    

TOPICS:

WHO: Millions of Ebola Vaccine Doses Ready in 2015

October 24, 2014 11:38 am | by Maria Cheng - AP Medical Writer - Associated Press | News | Comments

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March. Still, the agency warned it's not clear whether any of these will work against the deadly virus that has...

TOPICS:

Bristol-Myers Squibb Tops Wall Street Third Quarter Forecasts

October 24, 2014 8:39 am | by The Associated Press | News | Comments

Bristol-Myers Squibb reported third-quarter profit of $721 million. The New York-based company said it had profit of 43 cents per share. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The results beat Wall Street expectations.

TOPICS:

Pfizer Approves $11B Stock Repurchase Plan

October 23, 2014 4:38 pm | by The Associated Press | News | Comments

Pfizer says it approved the repurchase of $11 billion in company stock. The company did not say when it would buy back the shares. Pfizer has $1.3 billion remaining from its latest stock repurchase program.        

TOPICS:
Advertisement

CDC Details New Ebola Response and Prep Teams

October 23, 2014 2:11 pm | by MIKE STOBBE, AP Medical Writer | News | Comments

New federal Ebola response squads — likened to public health SWAT teams — are being readied to rush to any U.S. city where a new Ebola case might be identified, officials say.             

TOPICS:

Patent Expirations Hit Eli Lilly Third Quarter Profit

October 23, 2014 1:43 pm | News | Comments

Eli Lilly said that its net income and sales sank in the third quarter after its antidepressant Cymbalta lost patent protection and faced competition from less-expensive generics. Lilly said its revenue from Cymbalta plunged 73%t and revenue from the osteoporosis treatment Evista fell 65%.

TOPICS:

EMA to Start Assessment of Ebola Vaccines and Treatments as Soon as Data are Made Available

October 23, 2014 1:35 pm | News | Comments

The EMA has established a form of rolling review that allows experts to continuously assess incoming data and develop increasingly robust scientific opinions based on the additional data provided during the process. The initial review and subsequent updates will be shared with healthcare decision-makers in the most affected and other countries.

TOPICS:

Soliris Sales Boost Alexion's Third Quarter Results

October 23, 2014 1:21 pm | News | Comments

The company reported net product sales of Soliris® (eculizumab) of $555.1 million in the third quarter of 2014, an increase of 39 percent from the same period in 2013.              

TOPICS:

Ebola Patient Nina Pham's Dog Bentley is 'Doing Great'

October 23, 2014 11:08 am | Videos | Comments

The City of Dallas released new video of Bentley, who was quarantined when his owner was diagnosed with Ebola. Officials say he still tests negative.                 

TOPICS:

New Cancer Drug Could Be On the Horizon

October 23, 2014 11:01 am | Videos | Comments

Researchers in Chicago say that an experimental cancer drug is showing promise. Also, a new risk for bariatric surgery recipients.                    

TOPICS:

New Warning for Dietary Supplement Users

October 23, 2014 10:46 am | Videos | Comments

Researchers at Harvard found that two-thirds of dietary supplements that have previously been recalled still contain banned ingredients. Also, smoking may get in the way of recovering alcoholics.         

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading